TrialPancreas2019
A Phase II Trial of Ziv-Aflibercept in Patients With Advanced Pancreatic Neuroendocrine Tumors.
Daniel M Halperin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
TrialPancreas2019
Daniel M Halperin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.